Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/26/1998 | WO1998012344A1 Human tumor necrosis factor receptor-like genes |
03/26/1998 | WO1998012339A2 Viral vectors and their uses |
03/26/1998 | WO1998012338A1 Improved retroviral vectors for gene therapy |
03/26/1998 | WO1998012337A1 Random and targeted promoter integration for gene analysis |
03/26/1998 | WO1998012336A1 Artificial chromosome |
03/26/1998 | WO1998012335A1 Nematode-resistant gene |
03/26/1998 | WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
03/26/1998 | WO1998012333A1 Immunogenic peptides of foot-and-mouth disease viruses |
03/26/1998 | WO1998012332A1 Compositions and methods for treating intracellular diseases |
03/26/1998 | WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
03/26/1998 | WO1998012330A1 Mammalian cytokine, related reagents |
03/26/1998 | WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
03/26/1998 | WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use |
03/26/1998 | WO1998012327A2 Compositions and methods comprising bard1 and other brca1 binding proteins |
03/26/1998 | WO1998012326A1 Hedgehog interacting proteins and uses related thereto |
03/26/1998 | WO1998012325A1 Human gtp binding protein gamma-3 |
03/26/1998 | WO1998012324A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor |
03/26/1998 | WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto |
03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
03/26/1998 | WO1998012321A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster |
03/26/1998 | WO1998012316A1 Method for stably cloning large repeating dna sequences |
03/26/1998 | WO1998012314A1 Retroviral vectors capable of transducing non-dividing cells |
03/26/1998 | WO1998012312A1 Antisense gene therapy for rna viruses |
03/26/1998 | WO1998012311A2 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
03/26/1998 | WO1998012310A1 Method of transfecting cells by electroporation and apparatus for same |
03/26/1998 | WO1998012308A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation |
03/26/1998 | WO1998012307A1 Cellulase variants |
03/26/1998 | WO1998012306A1 Hematopoietic stem cells and methods for generating such cells |
03/26/1998 | WO1998012302A1 Weight control pathway genes and uses therefor |
03/26/1998 | WO1998012300A1 Novel host cells and methods of producing proteins |
03/26/1998 | WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/26/1998 | WO1998012223A1 Novel human interferon-inducible protein |
03/26/1998 | WO1998012220A2 Novel tumor proteins |
03/26/1998 | WO1998012207A1 High level expression of proteins |
03/26/1998 | WO1998012204A1 Human b-cell translocation genes-2 and 3 |
03/26/1998 | WO1998011989A1 Improved filtration system and method |
03/26/1998 | WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
03/26/1998 | WO1998011915A1 Strain selection of pneumococcal surface proteins |
03/26/1998 | WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
03/26/1998 | WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression |
03/26/1998 | WO1998007874A3 New systems for regulating genetic expression |
03/26/1998 | WO1998006835A3 Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
03/26/1998 | WO1998006827A3 Method for immortalizing cells |
03/26/1998 | WO1998005770A3 Antisense rna with a secondary structure |
03/26/1998 | WO1998003655A3 Gene expression regulatory dna, expression cassette, expression vector and transgenic plant |
03/26/1998 | WO1998003653A3 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
03/26/1998 | WO1998003538A3 Signal-regulated, cleavage-mediated toxins |
03/26/1998 | WO1998000695A3 Tat-sf: cofactor for stimulation of transcriptional elongation by hiv-1 tat |
03/26/1998 | WO1998000551A3 Gene encoding hyaluronan synthase |
03/26/1998 | WO1998000539A3 (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) |
03/26/1998 | WO1998000023A3 Plant protection method |
03/26/1998 | WO1997049832A3 Method of identifying cytochrome p450 |
03/26/1998 | WO1997048815A3 Method for enhancing gene transfer |
03/26/1998 | WO1997048812A3 Dna sequences encoding phytases of ruminal microorganisms |
03/26/1998 | WO1997048724A3 Human metabotropic glutamate receptor |
03/26/1998 | WO1997048370A3 Vaccines comprising synthetic genes |
03/26/1998 | WO1997047740A3 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN |
03/26/1998 | WO1997046672A3 Antisense nucleic acids and hammerhead ribozymes |
03/26/1998 | WO1997045541A3 Patched genes and their uses |
03/26/1998 | WO1997044447A3 Transcriptional activation system, activators, and uses therefor |
03/26/1998 | WO1997040162A3 Pesticidal toxins |
03/26/1998 | WO1997040072A3 Adam proteins and uses thereof |
03/26/1998 | WO1997040063A3 Pathogenic escherichia coli associated protein espa |
03/26/1998 | WO1997039030A3 Secreted proteins |
03/26/1998 | WO1997035990A3 Histone deacetylases, and uses related thereto |
03/26/1998 | DE19704301C1 Human endoglin gene promoter |
03/26/1998 | DE19641180A1 Verfahren zur Darstellung von APP-Sekretase Modulation und deren Verwendung als Mittel zur Behandlung der Alzheimer'schen Erkrankung A method for representation of APP-secretase modulation and their use as agents for the treatment of Alzheimer's disease |
03/26/1998 | DE19639103A1 DNA construct with inhibitory mutation and corrective mutation |
03/26/1998 | CA2267343A1 Strain selection of pneumococcal surface proteins |
03/26/1998 | CA2267288A1 Hematopoietic stem cells and methods for generating such cells |
03/26/1998 | CA2266745A1 Identification of molecular sequence signatures and methods involving the same |
03/26/1998 | CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
03/26/1998 | CA2266656A1 Compositions and methods for treating intracellular diseases |
03/26/1998 | CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/26/1998 | CA2266428A1 Method to detect dirofilaria immitis infection |
03/26/1998 | CA2266426A1 Method for stably cloning large repeating dna sequences |
03/26/1998 | CA2266425A1 Human b-cell translocation genes-2 and 3 |
03/26/1998 | CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
03/26/1998 | CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
03/26/1998 | CA2265939A1 Artificial chromosome |
03/26/1998 | CA2265898A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster |
03/26/1998 | CA2265702A1 Improved filtration system and method |
03/26/1998 | CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
03/26/1998 | CA2265522A1 Retroviral vectors capable of transducing non-dividing cells |
03/26/1998 | CA2265518A1 Immunogenic peptides of foot-and-mouth disease viruses |
03/26/1998 | CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression |
03/26/1998 | CA2264542A1 Human gtp binding protein gamma-3 |
03/26/1998 | CA2264487A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation |
03/26/1998 | CA2263821A1 Novel human interferon-inducible protein |
03/26/1998 | CA2263818A1 Novel tumor proteins |
03/26/1998 | CA2263801A1 Cephalosporin esterase gene from rhodosporidium toruloides |
03/26/1998 | CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same |
03/26/1998 | CA2216596A1 New high capacity binary shuttle vector |
03/25/1998 | EP0831150A1 PROCESS FOR INCREASING THE PRODUCTION OF PENICILLIN G (BENZYLPENICILLIN) IN PENICILLIUM CHRYSOGENUM THROUGH THE EXPRESSION OF THE GENE pcl |
03/25/1998 | EP0831149A1 Genes coding for biosynthetic enzyme group for icosapentaenoic acid and process for producing icosapentaenoic acid |
03/25/1998 | EP0831148A1 Human adhesion molecule occludin |
03/25/1998 | EP0830606A1 Assessing calcineurin's role in immunosuppression and neurotoxicity |
03/25/1998 | EP0830604A1 Methods and uses for apoptin |
03/25/1998 | EP0830600A1 Functional bioassay for g-protein coupled receptor agonists and antagonists |
03/25/1998 | EP0830595A1 Microelectrophoresis chip for moving and separating nucleic acids and other charged molecules |